Results 201 to 210 of about 883,314 (350)
ESC Heart Failure, Volume 12, Issue 4, Page 2759-2768, August 2025.Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner +10 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 4, Page 2460-2466, August 2025.Abstract Aims Early diuresis and natriuresis are commonly used to assess the efficacy of decongestive therapy following an acute heart failure episode. There is limited knowledge regarding which parameter better predicts adverse clinical outcomes, especially in the outpatient setting.
M. Cobo Marcos +15 more
wiley +1 more source
Clinical experiences of LVAD for acute myocardial infarction with cardiogenic shock.
, 1988 Y. Kito
openalex +2 more sources
ESC Heart Failure, Volume 12, Issue 4, Page 2791-2802, August 2025.Routine data analysis showing a better outcome regarding mortality and readmission in HF patients when being prescribed the current four‐drug treatment (vs. the outdated two‐drug therapy) 91–365 days after index hospital stay. Abstract Aims The 2021 European heart failure (HF) guidelines recommend the combination of four drugs as a standard therapy ...
Martin Möckel +9 more
wiley +1 more source
Learning from cardiogenic shock deaths: a comparative analysis between hypotensive and normotensive cardiogenic shock. [PDF]
Eur Heart J OpenTran P +8 more
europepmc +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
ESC Heart Failure, Volume 12, Issue 4, Page 2404-2416, August 2025.Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna +4 more
wiley +1 more source
The Effect of Early IABP and Reperfusion therapy in Patient of Post MI Cardiogenic shock [PDF]
, 2000 Jong-Suk Lee +8 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 4, Page 2552-2564, August 2025.In the context of patients with severe heart failure, it is crucial to ensure adequate preconditioning before considering the implantation of dLVAD. Although several types of mechanical circulatory assist devices are available and all offer a significant advantage, the present study suggests that the higher the flow rate provided by the Impella®, the ...
Marta L. Medina +32 more
wiley +1 more source